Voyageur Pharmaceuticals (CVE:VM) Shares Up 14.3% – Still a Buy?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM) were up 14.3% during trading on Tuesday . The stock traded as high as C$0.24 and last traded at C$0.24. Approximately 450,853 shares traded hands during mid-day trading, a decline of 2% from the average daily volume of 458,386 shares. The stock had previously closed at C$0.21.

Voyageur Pharmaceuticals Trading Up 21.2 %

The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The company has a fifty day moving average of C$0.10 and a two-hundred day moving average of C$0.07. The stock has a market capitalization of C$27.89 million, a price-to-earnings ratio of -20.00 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.